Cargando…
A case control study of sarcosine as an early prostate cancer detection biomarker
BACKGROUND: Sarcosine has been investigated as a prostate cancer biomarker with mixed results concerning its predictive power. We performed a case–control evaluation of the predictive value of serum sarcosine for early detection in a population-based cohort of men undergoing prostate-specific antige...
Autores principales: | Ankerst, Donna P., Liss, Michael, Zapata, David, Hoefler, Josef, Thompson, Ian M., Leach, Robin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591628/ https://www.ncbi.nlm.nih.gov/pubmed/26429735 http://dx.doi.org/10.1186/s12894-015-0095-5 |
Ejemplares similares
-
Sarcosine as a Potential Prostate Cancer Biomarker—A Review
por: Cernei, Natalia, et al.
Publicado: (2013) -
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial
por: Hernandez, Javier, et al.
Publicado: (2018) -
Identification of Sarcosine as a Target Molecule for the Canine Olfactory Detection of Prostate Carcinoma
por: Pacik, Dalibor, et al.
Publicado: (2018) -
A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing
por: Uhlirova, Dagmar, et al.
Publicado: (2018) -
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
por: Gelfond, Jonathan A., et al.
Publicado: (2022)